These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10376943)

  • 1. Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats.
    Zou LP; Ma DH; Levi M; Wahren B; Wei L; Mix E; van der Meide PH; Link H; Zhu J
    J Neuroimmunol; 1999 Feb; 94(1-2):109-21. PubMed ID: 10376943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
    Zhu J; Zou LP; Bakhiet M; Mix E
    J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats.
    Pelidou SH; Zou LP; Deretzi G; Nennesmo I; Wei L; Mix E; Van Der Meide PH; Zhu J
    Scand J Immunol; 2000 Jan; 51(1):29-35. PubMed ID: 10632973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P0 glycoprotein peptides 56-71 and 180-199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading.
    Zhu J; Pelidou SH; Deretzi G; Levi M; Mix E; van der Meide P; Winblad B; Zou LP
    J Neuroimmunol; 2001 Mar; 114(1-2):99-106. PubMed ID: 11240020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis.
    Duan RS; Chen Z; Bao L; Quezada HC; Nennesmo I; Winblad B; Zhu J
    Neurobiol Dis; 2004 Aug; 16(3):630-7. PubMed ID: 15262275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.
    Zou LP; Zhu J; Deng GM; Levi M; Wahren B; Diab A; Hillert J; Link H
    J Neuroimmunol; 1998 May; 85(2):137-45. PubMed ID: 9630162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1.
    Zhu J; Link H; Weerth S; Linington C; Mix E; Qiao J
    J Neurol Sci; 1994 Sep; 125(2):132-7. PubMed ID: 7528788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Jin T; Adem A; Zhu J
    Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats.
    Yun W; Hua-bing W; Wei-zhi W
    J Neuroimmunol; 2007 Apr; 185(1-2):87-94. PubMed ID: 17346805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis.
    Bao L; Lindgren JU; Zhu Yu; Ljunggren HG; Zhu J
    Neurobiol Dis; 2003 Feb; 12(1):73-81. PubMed ID: 12609491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.
    Bai XF; Zhu J; Zhang GX; Kaponides G; Höjeberg B; van der Meide PH; Link H
    Clin Immunol Immunopathol; 1997 May; 83(2):117-26. PubMed ID: 9143372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
    Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
    Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
    Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
    Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen.
    Yu S; Chen Z; Mix E; Zhu SW; Winblad B; Ljunggren HG; Zhu J
    J Neuropathol Exp Neurol; 2002 Jul; 61(7):614-22. PubMed ID: 12125740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade enhances incidence and severity of experimental autoimmune neuritis in resistant mice.
    Zhu J; Zou L; Zhu S; Mix E; Shi F; Wang H; Volkmann I; Winblad B; Schalling M; Ljunggren H
    J Neuroimmunol; 2001 Apr; 115(1-2):111-7. PubMed ID: 11282160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
    Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
    Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
    Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
    J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.